MADISON, Wis. - WisconsinEagle -- OnLume Inc., ("OnLume"), a medical device company developing novel imaging systems for use during surgery, announced that it had received 510(k) clearance from the U.S. Food & Drug Administration ("FDA") to market its first product, a fluorescence guided surgery (FGS) system.
The OnLume Imaging System is indicated for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive, and micro surgeries. This intraoperative imaging technology is used in conjunction with the FDA approved indocyanine green (ICG) dye with applications to several surgical specialties, including cardiac, gastrointestinal, and reconstructive surgery, for identifying regions of poor blood flow that may lead to post-surgical complications. The OnLume Imaging System has been demonstrated as safe and effective for these indications via the FDA 510(k) process.
More on Wisconsin Eagle
"We are very pleased to have received FDA 510(k) clearance for our clinical imaging system. This clearance is an important step in bringing our vision of fluorescence-guided surgery to market. Our technology gives surgeons key anatomical and functional insights in real-time during surgery, with the goal of improving patient outcomes and reducing healthcare costs," says OnLume CEO Adam Uselmann. "Our team is focused on developing a platform that provides clear imaging with ergonomics that are straightforward to integrate into existing surgical workflows. We look forward to expanding to new clinical indications as the field of FGS continues to grow."
OnLume is performing a limited product launch in Q1 2020, with a nationwide launch planned later this year.
The OnLume Imaging System is indicated for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive, and micro surgeries. This intraoperative imaging technology is used in conjunction with the FDA approved indocyanine green (ICG) dye with applications to several surgical specialties, including cardiac, gastrointestinal, and reconstructive surgery, for identifying regions of poor blood flow that may lead to post-surgical complications. The OnLume Imaging System has been demonstrated as safe and effective for these indications via the FDA 510(k) process.
More on Wisconsin Eagle
- Managecore to Host Live Virtual Meet Up Series Every Tuesday and Thursday for SAP Community
- Florida Governor Issues Stay-at-Home Order All Legal Proceedings Must Go Online
- AIS – All Integrated Solutions, Announces Its Supplier of the Year Award
- 230V in the vehicle made easy and powerful with an all-in-one inverter system
- Mahmood Khan Cracks ITUNES Australia Top Ten Charts
"We are very pleased to have received FDA 510(k) clearance for our clinical imaging system. This clearance is an important step in bringing our vision of fluorescence-guided surgery to market. Our technology gives surgeons key anatomical and functional insights in real-time during surgery, with the goal of improving patient outcomes and reducing healthcare costs," says OnLume CEO Adam Uselmann. "Our team is focused on developing a platform that provides clear imaging with ergonomics that are straightforward to integrate into existing surgical workflows. We look forward to expanding to new clinical indications as the field of FGS continues to grow."
OnLume is performing a limited product launch in Q1 2020, with a nationwide launch planned later this year.
Source: OnLume Inc.
0 Comments
Latest on Wisconsin Eagle
- Slim LED Light Box in 10mm,16mm and 20mm with 5 Years Warranty and Custom Sizes
- Class Claims LLC Announces Practice to Assist Businesses with Government Loans and Grants
- Madison: Actualización – Ciertas Restricciones de Estacionamiento en la Calle Temporalmente Suspendidas
- Madison: Update – Certain On-Street Parking Restrictions Temporarily Suspended
- Madison: CORRECTED Polling Place Listing for April 7
- ASI's 2020 Partner & Client Conference Goes Virtual as "iNNOVATIONS LIVE"
- Madison: Declaración de la Alcaldesa Rhodes-Conway con relación al COVID-19 y el Transporte
- Tampa President & Firm Found Guilty of Fraud - Plaintiff Awarded Nearly $1 Million
- Madison: April 1 is Census Day
- Madison: City of Fitchburg Street Reconstruction--Fish Hatchery Road
- Additional Information Regarding The MGIC Investment Corporation Annual Meeting Of Shareholders To Be Held On Thursday, April 23, 2020
- New Study: MindSciences Unwinding Anxiety App Reduces Physician Anxiety and Cynicism by Half
- Gempler's Ensures Employee Safety and Keeps Commitments to Essential Service Providers
- Advanced Fever-detection Technology to Protect Against COVID-19 Launched by National Life Safety / Security Provider
- Charlotte-Based Real Estate Tech Startup Close Off Market, Inc. Launches New (Beta) Platform
- Madison: Mayor Rhodes-Conway's Statement on Transportation in Regards to COVID-19
- Arizona Businesswoman Launches Giveaway to Support Students During School Closure
- Ideanomics Announces Operations Back to Normal; Announces $8.1 Million in Orders
- Madison: Polling Place Listing for April 7
- Trace-A-Matic Expands 5-Axis Machining Automation